ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 22 filers reported holding ONCOLYTICS BIOTECH INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $39,000 | +3800.0% | 8,390 | +503.6% | 0.00% | – |
Q3 2019 | $1,000 | -66.7% | 1,390 | 0.0% | 0.00% | – |
Q2 2019 | $3,000 | 0.0% | 1,390 | 0.0% | 0.00% | – |
Q1 2019 | $3,000 | 0.0% | 1,390 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | -50.0% | 1,390 | 0.0% | 0.00% | – |
Q3 2018 | $6,000 | – | 1,390 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Verition Fund Management LLC | 408,838 | $695,000 | 0.02% |
Magnus Financial Group LLC | 10,000 | $17,000 | 0.00% |
SCOTIA CAPITAL INC. | 48,039 | $83,000 | 0.00% |
HUNTINGTON NATIONAL BANK | 1,052 | $2,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 367 | $1,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 642 | $1,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
HOWE & RUSLING INC | 105 | $0 | 0.00% |
1832 Asset Management L.P. | 5 | $0 | 0.00% |
DEUTSCHE BANK AG\ | 4,601 | $7,000 | 0.00% |